Email Updates

You are here

HIV Vaccine Awareness Day

May 18 is the 22nd anniversary of HIV Vaccine Awareness Day (HVAD), a day when partners around the world join to celebrate the people, partnerships and science pushing ever closer to a safe, efficacious and accessible vaccine against HIV.

With three HIV vaccine efficacy trial programs currently underway—a first for the field—and many new discoveries from lab and clinical research, AVAC is excited by the momentum and progress as of 2019.

On the other hand, we’re alarmed by a global rise in what is sometimes called “vaccine hesitancy”, marked by measles outbreaks and a comeback of a disease almost eradicated through vaccination. Misinformation about vaccines could undo decades of progress in public health.

This HIV Vaccine Awareness Day, it’s time for a new global commitment to vaccine research, development and delivery.

HVAD Webinars

HIV Vaccine Science and Advocacy Priorities this HVAD

On May 16, Mary Marovich, the Director of the Vaccine Research Program at the Division of AIDS at the National Institute of Allergy and Infectious Diseases, and long-time HIV vaccine research advocate and community leader, Mark Hubbard, discussed the current landscape of vaccine research.

Recording: YouTube / Audio / Introductory Slides / Mary Marovich's Slides

Growing Epidemic of Vaccine Hesitancy and the Implications for Global Health

On Thursday May 23, Heidi Larson, Director of the Vaccine Confidence Project discussed the implications of vaccine hesitancy and other issues along with Laura Lopez Gonzalez, deputy editor of South Africa’s Bhekisisa Health Journalism Centre.

Recording: YouTube / Audio / Slides

Mitchell Warren, AVAC Executive Director, wrote about this topic in Science Speaks. Read "Will a vaccine crisis of confidence impact the global response to HIV?"

HVAD Toolkit

We created a toolkit to help you understand the current state of HIV vaccine research and to help you conduct outreach of your own. We’re especially excited this year about a set of infographics that explain key aspects of vaccine research—trial participant and enrollment numbers, global funding, trials timelines and more.


Other Materials